ZA805015B - Divisible tablet having controlled and delayed release of the active substance - Google Patents

Divisible tablet having controlled and delayed release of the active substance

Info

Publication number
ZA805015B
ZA805015B ZA00805015A ZA805015A ZA805015B ZA 805015 B ZA805015 B ZA 805015B ZA 00805015 A ZA00805015 A ZA 00805015A ZA 805015 A ZA805015 A ZA 805015A ZA 805015 B ZA805015 B ZA 805015B
Authority
ZA
South Africa
Prior art keywords
controlled
active substance
delayed release
divisible tablet
divisible
Prior art date
Application number
ZA00805015A
Inventor
C Voellmy
H Hess
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA805015B publication Critical patent/ZA805015B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
ZA00805015A 1979-08-16 1980-08-15 Divisible tablet having controlled and delayed release of the active substance ZA805015B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7514/79A CH648754A5 (en) 1979-08-16 1979-08-16 Pharmaceutical slow release tablet

Publications (1)

Publication Number Publication Date
ZA805015B true ZA805015B (en) 1981-08-26

Family

ID=4326338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00805015A ZA805015B (en) 1979-08-16 1980-08-15 Divisible tablet having controlled and delayed release of the active substance

Country Status (4)

Country Link
JP (1) JPS5659708A (en)
BE (1) BE884760A (en)
CH (1) CH648754A5 (en)
ZA (1) ZA805015B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8622513U1 (en) * 1986-02-24 1986-10-30 Smithkline Beckman Corp., Philadelphia, Pa. tablet
JP2577080Y2 (en) * 1991-09-10 1998-07-23 武田薬品工業株式会社 Dividable solid
UA67802C2 (en) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION
GB0030340D0 (en) * 2000-12-13 2001-01-24 Sorex Ltd Briquettes
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Anti-abuse dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (en) 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
ES2439572T3 (en) * 2004-05-21 2014-01-23 Accu-Break Technologies, Inc. Immediate-release pharmaceutical tablets of greater height than width
DE102004032049A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH Anti-abuse, oral dosage form
DE102005005449A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Process for producing an anti-abuse dosage form
WO2007058660A1 (en) * 2005-11-18 2007-05-24 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
EP2029116A4 (en) * 2006-06-19 2012-07-04 Accu Break Technologies Inc Segmented pharmaceutical dosage forms
WO2009092601A1 (en) 2008-01-25 2009-07-30 Grünenthal GmbH Pharmaceutical dosage form
FR2928836B1 (en) * 2008-03-21 2011-08-26 Servier Lab SECURE GALENIC FORM FOR MODIFIED RELEASE OF THE ACTIVE INGREDIENT
MX2010012039A (en) 2008-05-09 2010-11-30 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step.
RU2567723C2 (en) 2009-07-22 2015-11-10 Грюненталь Гмбх Oxidation stable and breaking resistance dosage form
BR112012001547A2 (en) 2009-07-22 2016-03-08 Gruenenthal Gmbh hot melt extruded pharmaceutical dosage form
PE20131126A1 (en) 2010-09-02 2013-10-21 Gruenenthal Chemie ALTERATION RESISTANT DOSAGE FORM INCLUDING AN ANIONIC POLYMER
RU2604676C2 (en) 2010-09-02 2016-12-10 Грюненталь Гмбх Destruction-resistant dosage form containing an inorganic salt
DK2736497T3 (en) 2011-07-29 2017-11-13 Gruenenthal Gmbh Shock-resistant tablet that provides an immediate release of a drug.
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
WO2013156453A1 (en) 2012-04-18 2013-10-24 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
TW201402155A (en) * 2012-06-12 2014-01-16 Daiichi Sankyo Co Ltd Tablet having ingestion easiness and dividability
AR096438A1 (en) 2013-05-29 2015-12-30 Gruenenthal Gmbh DOSAGE FORM RESISTANT TO INDEBITED USE WITH BIMODAL RELEASE PROFILE, PROCESS
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (en) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling.
JP5719479B1 (en) * 2013-12-09 2015-05-20 第一三共株式会社 Tablet with easy splitting
WO2015087561A1 (en) * 2013-12-09 2015-06-18 第一三共株式会社 Readily dividable tablet
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
JP2017516789A (en) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Multiparticulates protected against ethanol overdose
KR20170139158A (en) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 Immediate release and solvent extraction inhibition modulated dosage form
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations

Also Published As

Publication number Publication date
JPS6361928B2 (en) 1988-11-30
CH648754A5 (en) 1985-04-15
JPS5659708A (en) 1981-05-23
BE884760A (en) 1981-02-13

Similar Documents

Publication Publication Date Title
MY8700198A (en) Divisible tablet having controlled and delayed release of the active substance
ZA805015B (en) Divisible tablet having controlled and delayed release of the active substance
JPS5646822A (en) Medicine controlling active component release
EP0018605A3 (en) Enterosoluble capsule and methods for its preparation
JPS55141476A (en) 4hh3*11benzoxazine derivative*its manufacture and herbicide containing same as active substance
JPS55163057A (en) Powdered fireeextinguishing substance and its preparation
ZA804514B (en) Pharmacologically active substituted 3-amino-sydnone-imines processes for their preparation and their use
JPS5511570A (en) Antiipsoriasis active substance and its manufacture
GB2055369B (en) Insecticidally active acyl-ureas and their manufacture and use
EG14276A (en) Insecticidally active thiazolylideneoxo-propionitriles and their manufacture and use
CS192595B2 (en) Insecticide and acaricide means and method of making the active substances
CS186242B2 (en) Acaricide agent and mode of manufacture of active substances
IL59764A0 (en) Drug on the basis of dihydroergo-toxine and procedure for its manufacture
DE2860170D1 (en) Process for the preparation of polyisocyanates and their use
IL61764A0 (en) Solutions of bormoxynil and ioxynil esters
JPS56131509A (en) Agricultural drug and manufacture
DE2861245D1 (en) Process for the preparation of blocked polyisocyanates and blocked polyisocyanates obtainable thereby
JPS55136296A (en) Phosphorylhydrazine and insecticidal composition as active component of phosphorylhydrazine
JPS55100314A (en) Continuously releasing drug composition
JPS5620588A (en) 66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof
GB2048250B (en) 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses
GB1542414A (en) Arrangements for the controlled release of biologically active materials
CS192590B2 (en) Insecticide and acaricide means and method of making the active component
CS183843B2 (en) Insecticide and acaricide agent and mode of production of active substances
ZW18980A1 (en) Depot preparation with prolonged release of active substance